CRY2
CRY2 (cryptochrome circadian regulator 2) is a flavin adenine dinucleotide-binding transcriptional repressor and a core component of the circadian clock. It was previously named cryptochrome 2 (photolyase-like) and cryptochrome circadian clock 2. Browse Assay Genie's current range of CRY2 research reagents below, or read on for the biology behind the target.
CRY2 is a transcriptional repressor that forms part of the negative limb of the transcription/translation feedback loop driving the molecular circadian clock. CLOCK or NPAS2, paired with BMAL1 or BMAL2, activate clock genes through E-box elements. PER and CRY proteins then interact with this heterodimer and inhibit its activity, so negatively regulating their own expression. The gene is upregulated by CLOCK/ARNTL heterodimers and then represses that upregulation through PER/CRY heterodimers.
CRY1 and CRY2 have redundant functions but also make distinct contributions to the pace of the suprachiasmatic nucleus (SCN) clock. CRY2 is a less potent repressor than CRY1 in cerebellum and liver and is less effective at lengthening the period of the SCN oscillator. It appears to tune SCN circadian period by opposing CRY1. Together the two proteins are dispensable for rhythm generation but necessary for the development of intercellular networks that synchronise rhythms.
Beyond timekeeping, CRY2 is involved in glucose and lipid metabolism, in part through transcriptional regulation of genes such as LEP and ACSL4. It may block glucagon-mediated increases in cAMP and CREB1 phosphorylation, represses glucocorticoid receptor NR3C1/GR activity at glucocorticoid response elements, and represses CLOCK-BMAL1 induced transcription of BHLHE40/DEC1 and NAMPT. In skeletal muscle it represses PPARD and its target genes and limits exercise capacity.
The CRY2 gene encodes a flavoprotein of the DNA photolyase class-1 family that is widely conserved across plants and animals. Two transcript variants encoding different isoforms are known, and polymorphisms in the gene have been associated with altered sleep patterns. Disrupted circadian rhythms contribute to cardiovascular disease, cancer, metabolic syndromes and ageing.
CRY2 is a core clock component, making it central to studies of the feedback loop that generates roughly 24 hour rhythms in gene expression.
Polymorphisms in the CRY2 gene have been associated with altered sleep patterns, linking the protein to studies of sleep timing.
CRY2 modulates glucose and lipid metabolism and represses glucocorticoid receptor activity, and may limit glucagon-driven cAMP signalling.
Circadian disruption contributes to cardiovascular disease, cancer, metabolic syndromes and ageing, so clock regulators such as CRY2 are studied in these settings.
CRY2 is a transcriptional repressor in the negative limb of the circadian feedback loop. With PER proteins it inhibits the CLOCK/NPAS2-BMAL1/BMAL2 heterodimer. It also helps tune SCN period by opposing CRY1 and contributes to glucose and lipid metabolism.
HGNC lists the previous names cryptochrome 2 (photolyase-like) and cryptochrome circadian clock 2, and UniProt calls the protein Cryptochrome-2. NCBI Gene reports two transcript variants of the CRY2 gene that encode different isoforms.
Yes. NCBI Gene describes the encoded protein as widely conserved across plants and animals, and it belongs to the DNA photolyase class-1 family. Mouse and rat both have a Cry2 ortholog; check the datasheet of any product for its validated reactivity.
CRY1, the closest cryptochrome relative, together with other CRY-named targets that have pages at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q49AN0; product specifications from Assay Genie datasheets.